Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Palliat Support Care. 2024 Feb;22(1):10–18. doi: 10.1017/S1478951523000901

Table 3.

Patient clinical characteristics

Characteristic Patient M (SD) / N (%)
Cancer diagnoses
  Lung 5 (22.7%)
  Cervical 1 (4.5%)
  Ovarian 3 (13.6%)
  Uterine 2 (9.1%)
  Vulvar 1 (4.5%)
  Lymphoma 4 (18.2%)
  Other 2 (18.2%)
  Missing 2 (9.1%)
Cancer stage (current)
  Stage II 1 (4.5%)
  Stage III 1 (4.5%)
  Stage IV 16 (72.7%)
Metastasis indicated
  Yes 12 (54.5%)
  No 9 (40.9%)
  Missing 1 (4.5%)
Chemotherapy
  Yes 14 (63.6%)
  No 8 (36.4%)
Radiation therapy
  Yes 0 (0.0%)
  No 22 (100.0%)
Immunotherapy
  Yes 2 (9.1%)
  No 20 (90.9%)
Targeted therapy
  Yes 1 (4.5%)
  No 21 (95.5%)
Karnofsky Performance Score 9.00 (1.58)
ECOG Performance Score 1.41 (2.27)
*

Note: All information taken from medical record

M = Mean, SD = standard deviation, ECOG = Eastern Cooperative Oncology Group